US to resume J&J COVID vaccinations despite rare clot risk

U.S. health advisers on Friday urged resuming COVID-19 vaccinations with Johnson & Johnson's single-dose shot, saying its benefits outweigh a rare risk of blood clots - in line with Europe's rollout.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines

01:52

Judge: 3 men convicted in COVID-19 relief aid fraud

01:47

Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off

00:28

Rockland small businesses get COVID-19 reimbursement grant